Harris Todd's most recent trade in Tyra Biosciences Inc was a trade of 864 Common Stock done at an average price of $9.1 . Disclosure was reported to the exchange on Sept. 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 9.13 per share. | 15 Sep 2026 | 864 | 1,438,495 | - | 9.1 | 7,887 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | 05 May 2026 | 265,000 | 265,000 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2026 | 79,000 | 1,437,631 | - | 0 | Common Stock | |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 9.13 per share. | 13 Mar 2026 | 1,463 | 1,358,631 | - | 9.1 | 13,356 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 9.13 per share. | 13 Mar 2026 | 1,463 | 1,358,631 | - | 9.1 | 13,356 | - |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | 07 Aug 2025 | 570,000 | 570,000 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 9.78 per share. | 14 Mar 2025 | 1,241 | 1,357,168 | - | 9.8 | 12,131 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 27.01 per share. | 18 Oct 2024 | 43,636 | 1,375,011 | - | 27.0 | 1,178,796 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 28.16 per share. | 18 Oct 2024 | 13,188 | 1,355,927 | - | 28.2 | 371,370 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 27.32 per share. | 18 Oct 2024 | 5,896 | 1,369,115 | - | 27.3 | 161,081 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 26.23 per share. | 15 Oct 2024 | 24,475 | 1,437,963 | - | 26.2 | 642,062 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.84 per share. | 15 Oct 2024 | 15,194 | 1,418,847 | - | 25.8 | 392,598 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 24.31 per share. | 15 Oct 2024 | 10,035 | 1,467,338 | - | 24.3 | 243,970 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.22 per share. | 15 Oct 2024 | 4,900 | 1,462,438 | - | 25.2 | 123,556 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 26.98 per share. | 15 Oct 2024 | 3,922 | 1,434,041 | - | 27.0 | 105,811 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 26.37 per share. | 15 Oct 2024 | 200 | 1,418,647 | - | 26.4 | 5,274 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 24.00 per share. | 30 Sep 2024 | 500 | 1,477,373 | - | 24 | 12,000 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 24.13 per share. | 23 Sep 2024 | 10,092 | 1,479,528 | - | 24.1 | 243,477 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 24.02 per share. | 23 Sep 2024 | 1,055 | 1,478,473 | - | 24.0 | 25,341 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 24.01 per share. | 23 Sep 2024 | 600 | 1,477,873 | - | 24.0 | 14,406 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 24.19 per share. | 18 Sep 2024 | 7,109 | 1,489,620 | - | 24.2 | 171,950 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 24.30 per share. | 18 Sep 2024 | 5,671 | 1,496,756 | - | 24.3 | 137,813 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 24.00 per share. | 18 Sep 2024 | 3,500 | 1,502,427 | - | 24 | 84,000 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.11 per share. | 18 Sep 2024 | 27 | 1,496,729 | - | 25.1 | 678 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 6.58 per share. | 13 Sep 2024 | 1,350 | 1,505,927 | - | 6.6 | 8,882 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | 14 Aug 2024 | 390,000 | 390,000 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 6.58 per share. | 15 Mar 2024 | 1,880 | 1,504,577 | - | 6.6 | 12,369 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.45 per share. | 02 Feb 2024 | 78,996 | 1,523,701 | - | 16.4 | 1,299,160 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.97 per share. | 02 Feb 2024 | 13,817 | 1,502,697 | - | 17.0 | 234,430 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 17.04 per share. | 02 Feb 2024 | 7,187 | 1,516,514 | - | 17.0 | 122,495 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 6.58 per share. | 15 Sep 2023 | 1,421 | 1,602,697 | - | 6.6 | 9,349 | - |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, President and CEO | 28 Jul 2023 | 330,000 | 330,000 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.78 per share. | 22 Jun 2023 | 14,231 | 1,607,757 | - | 16.8 | 238,798 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.51 per share. | 22 Jun 2023 | 6,481 | 1,601,276 | - | 17.5 | 113,464 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.98 per share. | 22 Jun 2023 | 2,978 | 1,622,488 | - | 17.0 | 50,558 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.39 per share. | 22 Jun 2023 | 500 | 1,621,988 | - | 17.4 | 8,693 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.06 per share. | 16 Jun 2023 | 50,838 | 1,647,122 | - | 17.1 | 867,296 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.71 per share. | 16 Jun 2023 | 14,027 | 1,626,566 | - | 17.7 | 248,358 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.12 per share. | 16 Jun 2023 | 4,629 | 1,640,593 | - | 16.1 | 74,615 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.49 per share. | 16 Jun 2023 | 3,316 | 1,697,960 | - | 16.5 | 54,681 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.53 per share. | 16 Jun 2023 | 1,300 | 1,645,222 | - | 16.5 | 21,493 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.18 per share. | 16 Jun 2023 | 1,100 | 1,625,466 | - | 18.2 | 19,999 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.50 per share. | 16 Jun 2023 | 600 | 1,646,522 | - | 18.5 | 11,100 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | 13 Jun 2023 | 12,773 | 376,837 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.13 per share. | 13 Jun 2023 | 12,773 | 1,701,276 | - | 16.1 | 205,997 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. | 13 Jun 2023 | 12,773 | 1,714,049 | - | 2.2 | 28,739 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 13 Jun 2023 | 7,927 | 1,701,276 | - | 16.0 | 126,870 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. | 13 Jun 2023 | 7,927 | 1,709,203 | - | 2.3 | 17,836 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | 13 Jun 2023 | 7,927 | 389,610 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | 03 Apr 2023 | 2,000 | 397,537 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.13 per share. | 03 Apr 2023 | 2,000 | 1,701,276 | - | 16.1 | 32,252 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. | 03 Apr 2023 | 2,000 | 1,703,276 | - | 2.3 | 4,500 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | 29 Mar 2023 | 2,407 | 400,037 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.02 per share. | 29 Mar 2023 | 2,407 | 1,701,276 | - | 16.0 | 38,552 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. | 29 Mar 2023 | 2,407 | 1,703,683 | - | 2.3 | 5,416 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.18 per share. | 29 Mar 2023 | 1,420 | 1,701,276 | - | 16.2 | 22,981 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | 29 Mar 2023 | 1,420 | 402,444 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. | 29 Mar 2023 | 1,420 | 1,702,696 | - | 2.3 | 3,195 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | 29 Mar 2023 | 500 | 399,537 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.05 per share. | 29 Mar 2023 | 500 | 1,701,276 | - | 16.0 | 8,023 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. | 29 Mar 2023 | 500 | 1,701,776 | - | 2.3 | 1,125 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | 24 Mar 2023 | 2,963 | 406,643 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 24 Mar 2023 | 2,963 | 1,701,276 | - | 16 | 47,408 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. | 24 Mar 2023 | 2,963 | 1,704,239 | - | 2.3 | 6,667 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | 24 Mar 2023 | 2,779 | 403,864 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 24 Mar 2023 | 2,779 | 1,701,276 | - | 16 | 44,464 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. | 24 Mar 2023 | 2,779 | 1,704,055 | - | 2.3 | 6,253 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. | 24 Mar 2023 | 170 | 1,701,446 | - | 2.3 | 383 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | 24 Mar 2023 | 170 | 409,606 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 24 Mar 2023 | 170 | 1,701,276 | - | 16 | 2,720 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 21 Mar 2023 | 12,393 | 1,701,276 | - | 16 | 198,288 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | 21 Mar 2023 | 12,393 | 416,619 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. | 21 Mar 2023 | 12,393 | 1,713,669 | - | 2.2 | 27,884 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | 21 Mar 2023 | 4,043 | 412,576 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 21 Mar 2023 | 4,043 | 1,701,276 | - | 16 | 64,688 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. | 21 Mar 2023 | 4,043 | 1,705,319 | - | 2.3 | 9,097 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | 21 Mar 2023 | 2,800 | 409,776 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 21 Mar 2023 | 2,800 | 1,701,276 | - | 16 | 44,800 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. | 21 Mar 2023 | 2,800 | 1,704,076 | - | 2.3 | 6,300 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 6.58 per share. | 15 Mar 2023 | 1,808 | 1,701,276 | - | 6.6 | 11,895 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | 06 Sep 2022 | 270,000 | 270,000 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 8.53 per share. | 06 Sep 2022 | 3,125 | 1,699,468 | - | 8.5 | 26,642 | Common Stock |
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | 02 Nov 2021 | 215,038 | 215,038 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | 02 Nov 2021 | 25,884 | 25,884 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. Todd Harris, PhD | Director, Chief Executive Officer | 02 Nov 2021 | 25,884 | 25,884 | - | - | Stock Option (Right to Buy) |